SCHEMBL7472695

SCHEMBL7472695

COC1=CCc2cnc(Nc3ccc(N4CCN(CC=O)CC4)cc3)nc2C1C(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.42
KDR P35968 1/20 0.42
BRD4 O60885 5/20 0.41
CDK4 P11802 10/20 0.39
CCND1 P24385 9/20 0.39
CCNE1 P24864 5/20 0.39
CDK2 P24941 5/20 0.39
CDK1 P06493 2/20 0.39
CCNB1 P14635 2/20 0.39
CCND2 P30279 2/20 0.39
CCND3 P30281 2/20 0.39
CCNB2 O95067 1/20 0.39
CCNE2 O96020 1/20 0.39
FGFR1 P11362 1/20 0.39
CCNA2 P20248 1/20 0.39
FGFR2 P21802 1/20 0.39
FGFR4 P22455 1/20 0.39
FGFR3 P22607 1/20 0.39
CCNA1 P78396 1/20 0.39
CCNB3 Q8WWL7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7473002 0.92 EGFR (0.43) EGFRKDRBRD4CDK4CCND1
SCHEMBL7468168 0.88 CDK4 (0.40) EGFRKDRCDK4CCND1CCNE1
SCHEMBL7464943 0.87 EGFR (0.39) EGFRKDRBRD4CDK4CCND1
SCHEMBL6087469 0.87 CDK4 (0.51) EGFRKDRBRD4CDK4CCND1
SCHEMBL7469986 0.86 EGFR (0.38) EGFRKDRBRD4CDK4CCND1
SCHEMBL7463398 0.86 EGFR (0.42) EGFRKDRBRD4CDK4CCND1
SCHEMBL7470944 0.85 CDK4 (0.42) EGFRKDRCDK4CCND1CCNE1
SCHEMBL6086302 0.85 CDK4 (0.56) CDK4CCND1CCNE1CDK2SYK
SCHEMBL6089773 0.84 CDK4 (0.53) EGFRKDRBRD4CDK4CCND1
SCHEMBL6087809 0.84 SYK (0.51) EGFRCDK4CCND1CCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235815-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2002-09-04 EP claimed
WO-2001038315-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2001-05-31 WO claimed
EP-1235815-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2002-09-04 EP disclosed
WO-2001038315-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2001-05-31 WO disclosed